Alzheimer disease and other dementias (ADOD) have a substantial impact on the prevalence and costs of certain comorbid conditions compared with matched beneficiaries without ADOD.
Dirk Soenksen, MS, MBA
Advertisement
Articles by Dirk Soenksen, MS, MBA
Advertisement
Latest Updated Articles
- Impact of Dementia on Costs of Modifiable Comorbid Conditions
Published: November 8th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
Measles Outbreaks Cause Financial, Public Health Burden in US
3
New PBM Laws Seek to Protect Independent Pharmacies but Could Raise Costs, Limit Patient Access
4
Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes
5
